Characterization of monoclonal antibodies directed against squamous cell carcinoma antigens: Report of the TD-10 Workshop

Tumor Biology

Volumn 25, Issue 1-2, 2004, Pages 69-90

  Nustad, K ^a   Dowell, B L ^b   Davis, G J ^b   Stewart, K ^b   Nilsson, O ^c   Roijer E ^c   Suminami, Y ^d   Nawata, S ^d   Cataltepe, S ^e   Silverman, G A ^e   Kato, H ^a,d   De Bruijn, H W A ^f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b ABBOTT LABORATORIES   (United States)

^c Fujirebio Diagnostics Inc   (Sweden)

^d YAMAGUCHI UNIVERSITY   (Japan)

^e HARVARD MEDICAL SCHOOL   (United States)

^f UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Epitope mapping; Monoclonal antibodies; Squamous cell carcinoma antigen

Indexed keywords

CATHEPSIN G; CATHEPSIN L; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY SCC107; MONOCLONAL ANTIBODY SCC113; PROTEINASE; RECOMBINANT ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN; SQUAMOUS CELL CARCINOMA ANTIGEN 1; SQUAMOUS CELL CARCINOMA ANTIGEN 2; UNCLASSIFIED DRUG;

ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; BINDING AFFINITY; COMPLEX FORMATION; CONFERENCE PAPER; CONTROLLED STUDY; CROSS REACTION; EPITOPE MAPPING; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; SEQUENCE HOMOLOGY;

EID: 3042683159     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000077726     Document Type: Conference Paper

References (39)

1. Kato H, Torigoe T: Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977;40:1621-1628.
2. Suminami Y, Kishi F, Sekiguchi K, Kato H: Squamous cell carcinoma antigen is a new member of the serine protease inhibitors. Biochem Biophys Res Commun 1991;181:51-58.
3. Schneider SS, Schick C, Fish KE, Miller E, Pena JC, Treter SD, Hui SM, Silverman GA: A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci USA 1995;92:3147-3151.
4. Barnes RC, Worrall DM: Identification of a novel human serpin gene; cloning sequencing and expression of leupin. FEBS Lett 1995;373:61-65.
5. Hamada K, Shinomiya H, Asano Y, Kihana T, Iwamoto M, Hanakawa Y, Hashimoto K, Hirose S, Kyo S, Ito M: Molecular cloning of human squamous cell carcinoma antigen 1 gene and characterization of its promoter. Biochim Biophys Acta 2001;1518:124-131.
6. Schick C, Kamachi Y, Bartuski AJ, Cataltepe S, Schechter NM, Pemberton PA, Silverman GA: Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J Biol Chem 1997;272:1849-1855.
7. Schick C, Pemberton PA, Shi GP, Kamachi Y, Cataltepe S, Bartuski AJ, Gornstein ER, Bromme D, Chapman HA, Silverman GA: Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1:A kinetic analysis. Biochemistry 1998;37:5258-5266.
8. Cataltepe S, Gornstein ER, Schick C, Kamachi Y, Chatson K, Fries J, Silverman GA, Upton MP: Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem 2000;48:113-122.
9. Luke C, Schick C, Tsu C, Whisstock JC, Irving JA, Bromme D, Juliano L, Shi GP, Chapman HA, Silverman GA: Simple modifications of the serpin reactive site loop convert SCCA2 into a cysteine proteinase inhibitor: A critical role for the P3′ proline in facilitating RSL cleavage. Biochemistry 2000;39:7081-7091.
10. Suminami Y, Kishi F, Murakami A, Sakaguchi Y, Nawata S, Numa F, Kato H: Novel forms of squamous cell carcinoma antigen transcripts produced by alternative splicing. Biochim Biophys Acta 2001;1519:122-126.
11. Hussa RO, Maruo T, Strobel JL, Pattillo RA, Mochizuki M: Production of tumor-associated antigen, TA-4, by the CaSki cervical carcinoma cell line. Obstet Gynecol 1986;67:802-805.
12. Hamada K, Hanakawa Y, Hashimoto K, Iwamoto M, Kihana T, Hirose S, Nakamura M, Ito M: Gene expression of human squamous cell carcinoma antigens 1 and 2 in human cell lines. Oncol Rep 2001;8:347-354.
13. Suminami Y, Nagashima S, Vujanovic NL, Hirabayashi K, Kato H, Whiteside TL: Inhibition of apoptosis in human tumour cells by the tumour-associated serpin, SCC antigen-1. Br J Cancer 2000;82:981-989.
14. Murakami A, Suminami Y, Hirakawa H, Nawata S, Numa F, Kato H: Squamous cell carcinoma antigen suppresses radiation-induced cell death. Br J Cancer 2001;84:851-858.
15. McGettrick AF, Barnes RC, Worrall DM: SCCA2 inhibits TNF-mediated apoptosis in transfected HeLa cells. The reactive centre loop sequence is essential for this function and TNF-induced cathepsin G is a candidate target. Eur J Biochem 2001;268:5868-5875.
16. Al Khunaizi M, Luke CJ, Askew YS, Pak SC, Askew DJ, Cataltepe S, Miller D, Mills DR, Tsu C, Bromme D, Irving JA, Whisstock JC, Silverman GA: The serpin SQN-5 is a dual mechanistic-class inhibitor of serine and cysteine proteinases. Biochemistry 2002;41:3189-3199.
17. Huntington JA, Read RJ, Carrell RW: Structure of a serpin-protease complex shows inhibition by deformation. Nature 2000;407:923-926.
18. Hoshina M, Kimura A, Shibata K, Maruo T, Mochizuki M: Immunocytological distribution of the tumor antigen TA-4: Expression during carcinogenesis and maturation of squamous epithelium of human uterine cervix. Asia Oceania J Obstet Gynaecol 1986;12:119-126.
19. Takeshima N, Suminami Y, Takeda O, Abe H, Okuno N, Kato H: Expression of mRNA of SCC antigen in squamous cells. Tumor Biol 1992;13:338-342.
20. Maruo T, Shibata K, Kimura A, Hoshina M, Mochizuki M: Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix. Serial determinations and tissue localization. Cancer 1985;56:302-308.
21. Cataltepe S, Schick C, Luke CJ, Pak SC, Goldfarb D, Chen P, Tanasiyevic MJ, Posner MR, Silverman GA: Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2. Clin Chim Acta 2000;295:107-127.
22. Murakami A, Suminami Y, Sakaguchi Y, Nawata S, Numa F, Kishi F, Kato H: Specific detection and quantitation of SCC antigen 1 and SCC antigen 2 mRNAs by fluorescence-based asymmetric semi-nested reverse transcription PCR. Tumor Biol 2000;21:224-234.
23. Barnes RC, Coulter J, Worrall DM: Immunoreactivity of recombinant squamous cell carcinoma antigen and leupin/SCCA-2: Implications for tumor marker detection. Gynecol Oncol 2000;78:62-66.
24. Uemura Y, Pak SC, Luke C, Cataltepe S, Tsu C, Schick C, Kamachi Y, Pomeroy SL, Perlmutter DH, Silverman GA: Circulating serpin tumor markers SCCA1 and SCCA2 are not actively secreted but reside in the cytosol of squamous carcinoma cells. Int J Cancer 2000;89:368-377.
25. Takeshima N, Nakamura K, Takeda O, Morioka H, Tamura H, Takasugi N, Kato H: Individualization of the cutoff value for serum squamous-cell carcinoma antigen using a sensitive enzyme immunoassay. Tumor Biol 1990;11:167-172.
26. Kato H: Squamous cell carcinoma antigen; in Sell S (ed): Serological Cancer Markers. Totowa, Humana Press, 1992, pp 437-451.
27. Tsuyama S, Hashimoto K, Nakamura K, Tamura H, Sasaki K, Kato H: Different behaviors in the production and release of SCC antigen in squamous-cell carcinoma. Tumor Biol 1991;12:28-34.
28. Kato H: Studies on the special tumor marker of cervical cancer of the uterus. Semin Surg Oncol 1987;3:55-63.
29. Kato H, Morioka H, Hashimoto K, Suehiro Y, Hayashi K, Kobayashi M, Torigoe T: SCC antigen and its clinical applications; in Kato H, de Bruijn HWA, Ebert W, Herberman R, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princetown, Excerpta Medica, 1987, pp 1-14.
30. Molina R, Filella X, Lejarcegui JA, Pahisa J, Torné A, Rovirosa A, Mellado B, Ordi J, Puig-Tintore LM, Alicarte J, Biete A, Iglesias J: Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer. Tumor Biol 2003;24:156-164.
31. Tateiwa Y, Yoshida S, Miyahara Y, Hamana S, Motoyama S, Maruo T: Transient increase in squamous cell carcinoma antigen expression in cultured cervical carcinoma CaSki cells in response to exposure to cis- diamminedichloroplatinum. Tumor Biol 2003;24:219-227.
32. de Bruijn HW, Duk JM, van der Zee AG, Pras E, Willemse PH, Boonstra H, Hollema H, Mourits MJ, de Vries EG, Aalders JG: The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix. Tumor Biol 1998;19:505-516.
33. Maiman M: The clinical application of serum squamous cell carcinoma antigen level monitoring in invasive cervical carcinoma. Gynecol Oncol 2002;84:4-6.
34. Ikeda I: Two-site radioimmunometric (sandwich) assay of SCC antigen using monoclonal antibodies; in Kato H, de Bruijn HWA, Ebert W, Herberman R, Johnson JT (eds): SCC Antigen in the Management of Squamous Cell Carcinoma. Princetown, Excerpta Medica, 1987, pp 215-226.
35. Riöjer E, Kosinska U, Andersson I, Nilsson K, Nilsson O: Rearrangement of squamous cell carcinoma antigen genes - Detection of SCCA fusion transcripts. Tumor Biol 2003;24:46-52.
36. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951;193:265-275.
37. Nustad K, Lebedin Y, Lloyd KO, Shigemasa K, de Bruijn HW, Jansson B, Nilsson O, Olsen KH, O'Brien TJ; ISOBM TD-1 Workshop: Epitopes on CA 125 from cervical mucus and ascites fluid and characterization of six new antibodies. Third report from the ISOBM TD-1 workshop. Tumor Biol 2002;23:303-314.
38. Nawata S, Suminami Y, Hirakawa H, Murakami A, Ogata H, Numa F, Fujimoto M, Tanaka T, Nakamura K, Kato H: Nondenaturing two-dimensional electrophoretic analysis of loop-sheet polymerization of serpin, squamous cell carcinoma antigen-2. Electrophoresis 2001;22:161-164.
39. Heidtmann HH, Havemann K: Assay of complexed alpha 1-antichymotrypsin in plasma. Clin Chem 1993;39:869-874.